102 related articles for article (PubMed ID: 28218956)
1. Nasal budesonide efficacy for nasal nitric oxide and nasal obstruction in rhinitis.
Ferrante G; Fasola S; Cilluffo G; Malizia V; Montalbano L; Landi M; Passalacqua G; La Grutta S
Pediatr Allergy Immunol; 2017 Jun; 28(4):393-397. PubMed ID: 28218956
[No Abstract] [Full Text] [Related]
2. Montelukast decreased exhaled nitric oxide in children with perennial allergic rhinitis.
Hung CH; Hua YM; Hsu WT; Lai YS; Yang KD; Jong YJ; Chu YT
Pediatr Int; 2007 Jun; 49(3):322-7. PubMed ID: 17532829
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of the topical nasal steroid budesonide on improving sleep and daytime somnolence in patients with perennial allergic rhinitis.
Hughes K; Glass C; Ripchinski M; Gurevich F; Weaver TE; Lehman E; Fisher LH; Craig TJ
Allergy; 2003 May; 58(5):380-5. PubMed ID: 12797340
[TBL] [Abstract][Full Text] [Related]
4. The effect of intranasal steroid budesonide on the congestion-related sleep disturbance and daytime somnolence in patients with perennial allergic rhinitis.
Gurevich F; Glass C; Davies M; Wei W; McCann J; Fisher L; Chegini S; Mende C; Craig T
Allergy Asthma Proc; 2005; 26(4):268-74. PubMed ID: 16270719
[TBL] [Abstract][Full Text] [Related]
5. Intranasal budesonide in children affected by persistent allergic rhinitis and its effect on nasal patency and Nasal Obstruction Symptom Evaluation (NOSE) score.
Zicari AM; Occasi F; Montanari G; Indinnimeo L; De Castro G; Tancredi G; Duse M
Curr Med Res Opin; 2015 Mar; 31(3):391-6. PubMed ID: 25629793
[TBL] [Abstract][Full Text] [Related]
6. A pilot study of the effects of intranasal budesonide delivered by NasoNeb® on patients with perennial allergic rhinitis.
Brown K; Lane J; Silva MP; DeTineo M; Naclerio RM; Baroody FM
Int Forum Allergy Rhinol; 2014 Jan; 4(1):43-8. PubMed ID: 24574125
[TBL] [Abstract][Full Text] [Related]
7. The effect of intranasal corticosteroids on asthma control and quality of life in allergic rhinitis with mild asthma.
Scichilone N; Arrigo R; Paternò A; Santagata R; Impellitteri S; Braido F; Baiardini I; Battaglia S; Walter Canonica G; Bellia V
J Asthma; 2011 Feb; 48(1):41-7. PubMed ID: 21050027
[TBL] [Abstract][Full Text] [Related]
8. A comparison of nasal clearance after treatment of perennial allergic rhinitis with budesonide and mometasone.
Naclerio RM; Baroody FM; Bidani N; De Tineo M; Penney BC
Otolaryngol Head Neck Surg; 2003 Feb; 128(2):220-7. PubMed ID: 12601318
[TBL] [Abstract][Full Text] [Related]
9. Sleep disordered breathing and daytime quality of life in children with allergic rhinitis during treatment with intranasal budesonide.
Mansfield LE; Diaz G; Posey CR; Flores-Neder J
Ann Allergy Asthma Immunol; 2004 Feb; 92(2):240-4. PubMed ID: 14989393
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Odiosoft-Rhino in assessment of nasal obstruction: a comparative study with acoustic rhinometry after treatment with budesonide nasal spray in patients with perennial allergic rhinitis.
Tahamiler R; Yener M; Canakcioglu S
Am J Rhinol; 2007; 21(6):711-5. PubMed ID: 18201452
[TBL] [Abstract][Full Text] [Related]
11. Clinical and antiinflammatory effects of intranasal budesonide aqueous pump spray in the treatment of perennial allergic rhinitis.
Meltzer EO
Ann Allergy Asthma Immunol; 1998 Aug; 81(2):128-34. PubMed ID: 9723557
[TBL] [Abstract][Full Text] [Related]
12. Nasal inhalation of budesonide from a spacer in children with perennial rhinitis and asthma.
Pedersen W; Hjuler I; Bisgaard H; Mygind N
Allergy; 1998 Apr; 53(4):383-7. PubMed ID: 9574880
[TBL] [Abstract][Full Text] [Related]
13. A double blind comparison of intranasal budesonide 400 micrograms and 800 micrograms in perennial rhinitis.
Wight RG; Jones AS; Beckingham E; Andersson B; Ek L
Clin Otolaryngol Allied Sci; 1992 Aug; 17(4):354-8. PubMed ID: 1526057
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of mometasone furoate nasal spray for nasal symptoms, quality of life, rhinitis-disturbed sleep, and nasal nitric oxide in patients with perennial allergic rhinitis.
Yamada T; Yamamoto H; Kubo S; Sakashita M; Tokunaga T; Susuki D; Narita N; Ogi K; Kanno M; Yamashita S; Terasawa Y; Kayano Y; Masada M; Fujieda S
Allergy Asthma Proc; 2012; 33(2):e9-16. PubMed ID: 22525384
[TBL] [Abstract][Full Text] [Related]
15. [Nasal budesonide plus zafirlukast vs nasal budesonide plus loratadine-pseudoephedrine for controlling the symptoms of rhinitis and asthma].
Benitez HH; Arvizu VM; Gutiérrez DJ; Fogelbach GA; Castellanos Olivares A; Vázquez Nava F; Velázquez HC; González Pérez Mdel C; Mora Nieto A; Rodríguez EC
Rev Alerg Mex; 2005; 52(2):90-5. PubMed ID: 16158782
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of intranasal budesonide in the treatment of perennial rhinitis in adults and children.
Day JH; Andersson CB; Briscoe MP
Ann Allergy; 1990 May; 64(5):445-50. PubMed ID: 2186673
[TBL] [Abstract][Full Text] [Related]
17. [Effect of topical steroid on oral and nasal nitric oxide production in patients with allergic rhinitis].
Gao Q; Zhang Y; Wang C; Zhao Y; Zhang L
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Oct; 25(20):913-5, 919. PubMed ID: 22239049
[TBL] [Abstract][Full Text] [Related]
18. Safety of nasal budesonide in the long-term treatment of children with perennial rhinitis.
Möller C; Ahlström H; Henricson KA; Malmqvist LA; Akerlund A; Hildebrand H
Clin Exp Allergy; 2003 Jun; 33(6):816-22. PubMed ID: 12801318
[TBL] [Abstract][Full Text] [Related]
19. Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: a pilot study.
Ciprandi G; Cirillo I; Vizzaccaro A; Civardi E; Barberi S; Allen M; Marseglia GL
Int Immunopharmacol; 2005 Dec; 5(13-14):1800-8. PubMed ID: 16275616
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of nasal symptoms and mucociliary function in patients with allergic rhinitis treated with chemosurgery using trichloroacetic acid.
Unsal Tuna EE; Ozbek C; Koç C; Ozdem C
Am J Otolaryngol; 2008; 29(1):37-41. PubMed ID: 18061830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
